<SEC-DOCUMENT>0001178913-23-002033-index.html : 20230524
<SEC-HEADER>0001178913-23-002033.hdr.sgml : 20230524
<ACCEPTANCE-DATETIME>20230524070605
ACCESSION NUMBER:		0001178913-23-002033
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20230524
FILED AS OF DATE:		20230524
DATE AS OF CHANGE:		20230524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioLineRx Ltd.
		CENTRAL INDEX KEY:			0001498403
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35223
		FILM NUMBER:		23950583

	BUSINESS ADDRESS:	
		STREET 1:		2 HAMA-AYAN STREET
		STREET 2:		MODI-IN TECHNOLOGY PARK
		CITY:			MODI-IN
		STATE:			L3
		ZIP:			7177871
		BUSINESS PHONE:		972-2-548-9100

	MAIL ADDRESS:	
		STREET 1:		2 HAMA-AYAN STREET
		STREET 2:		MODI-IN TECHNOLOGY PARK
		CITY:			MODI-IN
		STATE:			L3
		ZIP:			7177871

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioLineRX, Ltd.
		DATE OF NAME CHANGE:	20100805
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2329789.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: zk2329789.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exhibit_1.htm
<DESCRIPTION>REGISTRANT'S PRESS RELEASE DATED MAY 24, 2023;
<TEXT>
Document 2 - file: exhibit_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>exhibit_2.htm
<DESCRIPTION>REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, 2023 AND FOR THE THREE THEN ENDED; AND
<TEXT>
Document 3 - file: exhibit_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>4
<FILENAME>exhibit_3.htm
<DESCRIPTION>REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF MARCH 31, 2023 AND FOR THE THREE THEN ENDED.
<TEXT>
Document 4 - file: exhibit_3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image0.jpg
<TEXT>
Document 5 - file: image0.jpg

</DOCUMENT>
</SEC-DOCUMENT>